• Miltefosine Promotes Neutrophil Differentiation via Ras/MEK/

  2026-07-28

  This study demonstrates that Miltefosine, a phospholipid analogue, robustly promotes neutrophil differentiation by activating the Ras/MEK/ERK pathway. The findings provide a mechanistic and translational basis for employing Miltefosine to restore bone marrow and immune function in models of leukopenia, suggesting new therapeutic avenues for myelosuppression.

• Cy5 amine (non-sulfonated): Technical Guide and Protocols

  2026-07-28

  Cy5 amine (non-sulfonated) addresses the need for a highly photostable, amine-functionalized cyanine dye suitable for sensitive, covalent labeling in non-aqueous workflows such as protein, peptide, or polymer conjugation. It is specifically designed for research fluorescence applications, but is not suitable for direct use in aqueous solutions, diagnostic, or medical contexts.

• BAPTA-AM: Cell-Permeable Calcium Chelator for Advanced Assay

  2026-07-27

  BAPTA-AM from APExBIO empowers precise, real-time modulation of intracellular calcium for advanced apoptosis, neuroprotection, and arrhythmia research. Leveraging its dual action as a chelator and potassium channel blocker, researchers gain control over cell fate decisions and functional readouts in live-cell systems.

• Y-27632: Applied ROCK Inhibitor Strategies for Cell Models

  2026-07-27

  Y-27632 unlocks precise, reproducible control of cytoskeletal dynamics in advanced cell models, from high-throughput gastruloid arrays to patient-derived organoids. This guide details optimized protocols, troubleshooting tactics, and comparative advantages in ROCK signaling pathway research, leveraging APExBIO’s rigorously validated Y-27632.

• AngII Drives Macrophage M1 Polarization via Cx43/NF-κB Pathw

  2026-07-26

  This study demonstrates that angiotensin II (AngII) induces RAW264.7 macrophage polarization toward a pro-inflammatory M1 phenotype through the connexin 43 (Cx43)/NF-κB signaling axis. Importantly, selective inhibition of Cx43 hemichannels—such as with Gap19—suppresses key inflammatory markers, with implications for immune modulation in cardiovascular and neuroinflammatory disease models.

• 2'3'-cGAMP (sodium salt): Enhancing STING Pathway Assays

  2026-07-25

  2'3'-cGAMP (sodium salt) unlocks robust, reproducible activation of the cGAS-STING signaling pathway, outperforming other STING agonists in affinity and solubility. This article reveals optimized workflows, troubleshooting strategies, and experimental insights, all grounded in the latest mechanistic research.

• Cinoxacin: Quinolone Antibiotic Benchmarks for UTI Research

  2026-07-24

  Cinoxacin is a well-characterized quinolone antibiotic effective against most Gram-negative uropathogens, inhibiting bacterial DNA synthesis with bactericidal efficacy. This article consolidates quantitative benchmarks, protocol parameters, and application boundaries for Cinoxacin in urinary tract infection research.

• Halazone: Bridging Antimicrobial Power and Sodium Channel In

  2026-07-24

  This thought-leadership article explores Halazone’s dual-action mechanism as both a broad-spectrum bactericidal disinfectant and a modulator of neuronal sodium channel inactivation. By dissecting its chemical rationale, translational research protocols, and validated performance, we provide strategic guidance for researchers across microbiology and neurophysiology. The discussion leverages quantitative literature, competitive benchmarking, and emergent translational opportunities, with a forward-looking perspective on Halazone’s future in resistance research and neurotherapeutics.

• Phillygenin Attenuates Diabetic Nephropathy via TLR4 and PI3

  2026-07-23

  The referenced study demonstrates that phillygenin, a Forsythia suspensa compound, significantly reduces inflammation and apoptosis in diabetic nephropathy by modulating TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β signaling. These findings highlight phillygenin’s potential as a mechanistically distinct therapeutic approach for diabetic kidney injury, with implications for broader intervention strategies targeting inflammatory and cell survival pathways.

• Targeted Lipid Nanoparticles Deliver EPO mRNA for SCI Neuror

  2026-07-23

  This study introduces an inflammation-targeted mannose-modified lipid nanoparticle system for localized delivery of human erythropoietin mRNA, achieving site-specific neuroprotection in spinal cord injury (SCI) models. The findings demonstrate the suppression of ferroptosis and neuroinflammation, providing a mechanistic advance for mRNA-based therapies in neurorepair.

• SM-102 in mRNA Delivery: Redefining Localized Cancer Therapy

  2026-07-22

  Explore how SM-102, a leading lipid nanoparticle component, is enabling precision mRNA delivery for localized cancer therapies. This article uniquely analyzes the molecule’s role in intravesical mRNA delivery, referencing recent breakthroughs in bladder cancer treatment.

• Silymarin’s Silybin A: Protocols and Innovations in Liver Re

  2026-07-22

  Silybin A, the bioactive core of Silymarin, enables high-fidelity liver disease and metabolic research with unmatched reproducibility and protocol clarity. This guide details robust workflows, advanced applications, and pragmatic troubleshooting for leveraging APExBIO’s Silybin A in oxidative stress and hepatoprotection studies.

• Novobiocin Sodium: Optimizing DNA and Parasite Research Work

  2026-07-21

  Novobiocin Sodium, a high-purity aminocoumarin antibiotic, empowers precise DNA damage, apoptosis, and anti-parasitic assays in cutting-edge research settings. Learn how to leverage its selective DNA gyrase inhibition for robust workflows, effective troubleshooting, and advanced applications, as highlighted by recent cross-kingdom studies.

• Losartan for Hypertension Research: Protocols and Innovation

  2026-07-21

  Losartan stands out as a selective angiotensin II receptor antagonist, enabling researchers to dissect cardiovascular mechanisms and model hypertension with precision. This article offers stepwise workflows, troubleshooting strategies, and practical insights—anchored in recent discoveries and APExBIO's trusted product performance.

• Live-Dead Cell Staining Kit: Advanced Viability Analysis for

  2026-07-20

  Discover how the Live-Dead Cell Staining Kit empowers high-precision cell viability assays for biomaterials and hemostatic research. This article delivers a deeper technical perspective, bridging dual-fluorescent staining with innovations in wound healing and cytotoxicity testing.

15371 records 1/1025 page Next 12345 下5页 Last page